PMID: 6989167Jan 1, 1980Paper

The effect of renal transplantation on basal serum gastrin concentration

Acta Medica Scandinavica
H E NielsenO Brandsborg


Basal serum gastrin concentration was measured before and every week during the initial 5 weeks after renal transplantation in 9 of 20 patients with chronic renal failure who obtained a well functioning renal transplant. Furthermore, calcium and phosphorus metabolism in relation to serum gastrin was investigated in all 20 patients 5 weeks after transplantation. Before renal transplantation, serum gastrin was markedly elevated as compared with the levels in normal controls. During the first 3-5 weeks after renal transplantation, serum gastrin decreased towards normal values. A slight but significant increase in serum gastrin persisted 5 weeks after transplantation. No significant relation between changes in serum gastrin concentration and in calcium and phosphorus metabolism was observed.


Jan 1, 1977·Scandinavian Journal of Gastroenterology·C K ChristensenO Brandsborg
Jul 1, 1979·Acta Endocrinologica·C K ChristensenO Brandsborg
Jan 22, 1972·British Medical Journal·M G KormanJ Hansky
Dec 1, 1970·The Journal of Clinical Investigation·R ArdaillouC Beaugas
Aug 1, 1969·The Journal of Clinical Investigation·A SilversG M Reaven


Sep 1, 1985·Scandinavian Journal of Gastroenterology·H Paimela
Nov 11, 1982·Pflügers Archiv : European journal of physiology·J LolyA Nizet

Related Concepts

Kidney Failure, Chronic
Red Phosphorus
Transplantation, Homologous
Kidney Transplantation

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.